290 related articles for article (PubMed ID: 23807646)
1. NF-κB and systemic lupus erythematosus: examining the link.
Zubair A; Frieri M
J Nephrol; 2013; 26(6):953-9. PubMed ID: 23807646
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus: all roads lead to type I interferons.
Pascual V; Farkas L; Banchereau J
Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis.
Lorenz G; Anders HJ
Semin Nephrol; 2015 Sep; 35(5):410-26. PubMed ID: 26573544
[TBL] [Abstract][Full Text] [Related]
4. New insights into the immunopathogenesis of systemic lupus erythematosus.
Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
[TBL] [Abstract][Full Text] [Related]
5. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
[TBL] [Abstract][Full Text] [Related]
6. Aberrant B cell selection and activation in systemic lupus erythematosus.
Kil LP; Hendriks RW
Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
[TBL] [Abstract][Full Text] [Related]
7. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
Mohan C; Putterman C
Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in the key events of systemic lupus erythematosus pathogenesis.
Husakova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):327-42. PubMed ID: 27003314
[TBL] [Abstract][Full Text] [Related]
9. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
10. NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.
Brightbill HD; Suto E; Blaquiere N; Ramamoorthi N; Sujatha-Bhaskar S; Gogol EB; Castanedo GM; Jackson BT; Kwon YC; Haller S; Lesch J; Bents K; Everett C; Kohli PB; Linge S; Christian L; Barrett K; Jaochico A; Berezhkovskiy LM; Fan PW; Modrusan Z; Veliz K; Townsend MJ; DeVoss J; Johnson AR; Godemann R; Lee WP; Austin CD; McKenzie BS; Hackney JA; Crawford JJ; Staben ST; Alaoui Ismaili MH; Wu LC; Ghilardi N
Nat Commun; 2018 Jan; 9(1):179. PubMed ID: 29330524
[TBL] [Abstract][Full Text] [Related]
11. Lupus nephritis: role of antinucleosome autoantibodies.
van der Vlag J; Berden JH
Semin Nephrol; 2011 Jul; 31(4):376-89. PubMed ID: 21839371
[TBL] [Abstract][Full Text] [Related]
12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
13. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
14. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Wong HK; Kammer GM; Dennis G; Tsokos GC
J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus conundrums.
Wardle EN
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
[TBL] [Abstract][Full Text] [Related]
16. [Novel therapeutic possibilities in systemic lupus erythematosus].
Bazsó A; Poór G; Gergely P; Kiss E
Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
[TBL] [Abstract][Full Text] [Related]
17. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
[TBL] [Abstract][Full Text] [Related]
18. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor activation in the pathogenesis of lupus nephritis.
Lorenz G; Lech M; Anders HJ
Clin Immunol; 2017 Dec; 185():86-94. PubMed ID: 27423476
[TBL] [Abstract][Full Text] [Related]
20. Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus.
Ma K; Du W; Wang X; Yuan S; Cai X; Liu D; Li J; Lu L
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
